glp 1 addiction trials GLP-1 drugs may fight across every major substance, according to a study of 600,000 people GLP-1 drugs for addiction: Confidence

[DOI] [PMC free article] [PubMed] [Google Scholar] 99.Ferhat M., Funai K., Boudina S

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs that targets incretin hormone pathways

Until we have larger, more definitive studies, the safest approach is still to stop GLP-1 medications before trying to conceive. The findings, however, are exactly the kind of data we need to justify properly designed prospective trials, says Lora Shahine, MD, a reproductive endocrinologist and obstetrician-gynecologist at PNWF IVY Fertility Center in Bellevue, Washington, and host of the Brave and Curious podcast

Then you have Big Pharma, which she thinks is responsible for labeling obesity a disease not to help people but to sell expensive drugs for weight loss, cardiovascular health, blood pressure, and more

Rotating injection sites is crucial to prevent cumulative irritation

This article profiles these trials and their implications for management of CVD in people with obesity after briefly tracing the path to the launch of these studies